NOF CORPORATION

NOF CORPORATION, the leading commercial supplier of drug delivery products from R&D through to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for the formulation of biological medicines, PEG lipids, and ionizable lipids for lipid nanoparticle (LNP) formulations.

Their LNP platform, composed of the COATSOME® SS Series of novel biodegradable ionizable lipids, demonstrates superior endosomal escape and enables high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccines, and in vitro transfection. It is capable of encapsulating pDNA, siRNA, and mRNA, delivering these to numerous organs and tissues.

NOF’s LNP platform is increasingly being adopted in clinical planning by its collaborators.

quick proposal

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.